Chemically triggered drug release from an antibody-drug conjugate leads to potent antitumour activity in mice
出版年份 2018 全文链接
标题
Chemically triggered drug release from an antibody-drug conjugate leads to potent antitumour activity in mice
作者
关键词
-
出版物
Nature Communications
Volume 9, Issue 1, Pages -
出版商
Springer Nature
发表日期
2018-04-11
DOI
10.1038/s41467-018-03880-y
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- α- Versus β-Emitting Radionuclides for Pretargeted Radioimmunotherapy of Carcinoembryonic Antigen–Expressing Human Colon Cancer Xenografts
- (2017) Sandra Heskamp et al. JOURNAL OF NUCLEAR MEDICINE
- Strategies and challenges for the next generation of antibody–drug conjugates
- (2017) Alain Beck et al. NATURE REVIEWS DRUG DISCOVERY
- Controlled in-cell activation of RNA therapeutics using bond-cleaving bio-orthogonal chemistry
- (2017) Irfan Khan et al. Chemical Science
- Determination of Cellular Processing Rates for a Trastuzumab-Maytansinoid Antibody-Drug Conjugate (ADC) Highlights Key Parameters for ADC Design
- (2016) Katie F. Maass et al. AAPS Journal
- Optimized Tetrazine Derivatives for Rapid Bioorthogonal Decaging in Living Cells
- (2016) Xinyuan Fan et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Combining antibody–drug conjugates and immune-mediated cancer therapy: What to expect?
- (2016) Hans-Peter Gerber et al. BIOCHEMICAL PHARMACOLOGY
- Triggered Drug Release from an Antibody–Drug Conjugate Using Fast “Click-to-Release” Chemistry in Mice
- (2016) Raffaella Rossin et al. BIOCONJUGATE CHEMISTRY
- Design, Synthesis, and Evaluation of a Low-Molecular-Weight 11C-Labeled Tetrazine for Pretargeted PET Imaging Applying Bioorthogonal in Vivo Click Chemistry
- (2016) Christoph Denk et al. BIOCONJUGATE CHEMISTRY
- Non-internalizing antibody-drug conjugates display potent anti-cancer activity upon proteolytic release of monomethyl auristatin E in the subendothelial extracellular matrix
- (2016) Rémy Gébleux et al. INTERNATIONAL JOURNAL OF CANCER
- Bioorthogonal Chemical Activation of Kinases in Living Systems
- (2016) Gong Zhang et al. ACS Central Science
- In Vivo Bioorthogonal Chemistry Enables Local Hydrogel and Systemic Pro-Drug To Treat Soft Tissue Sarcoma
- (2016) Jose M. Mejia Oneto et al. ACS Central Science
- Emerging formats for next-generation antibody drug conjugates
- (2015) Mahendra P Deonarain et al. Expert Opinion on Drug Discovery
- Development of a18F-Labeled Tetrazine with Favorable Pharmacokinetics for Bioorthogonal PET Imaging
- (2014) Christoph Denk et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Curative Properties of Noninternalizing Antibody-Drug Conjugates Based on Maytansinoids
- (2014) E. Perrino et al. CANCER RESEARCH
- Diels-Alder reaction–triggered bioorthogonal protein decaging in living cells
- (2014) Jie Li et al. Nature Chemical Biology
- Click to Release: Instantaneous Doxorubicin Elimination upon Tetrazine Ligation
- (2013) Ron M. Versteegen et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Highly Reactive trans-Cyclooctene Tags with Improved Stability for Diels–Alder Chemistry in Living Systems
- (2013) Raffaella Rossin et al. BIOCONJUGATE CHEMISTRY
- Diels-Alder Reaction for Tumor Pretargeting: In Vivo Chemistry Can Boost Tumor Radiation Dose Compared with Directly Labeled Antibody
- (2013) R. Rossin et al. JOURNAL OF NUCLEAR MEDICINE
- Site-Specific Conjugation of Monodispersed DOTA-PEGn to a Thiolated Diabody Reveals the Effect of Increasing PEG Size on Kidney Clearance and Tumor Uptake with Improved 64-Copper PET Imaging
- (2011) Lin Li et al. BIOCONJUGATE CHEMISTRY
- Investigational antibody drug conjugates for solid tumors
- (2011) Puja Sapra et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- In Vivo Chemistry for Pretargeted Tumor Imaging in Live Mice
- (2010) Raffaella Rossin et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Use of antibodies and immunoconjugates for the therapy of more accessible cancers
- (2008) Robert M. Sharkey et al. ADVANCED DRUG DELIVERY REVIEWS
- Antibody tumor penetration: Transport opposed by systemic and antigen-mediated clearance
- (2008) Greg M. Thurber et al. ADVANCED DRUG DELIVERY REVIEWS
- High Shed Antigen Levels within Tumors: An Additional Barrier to Immunoconjugate Therapy
- (2008) Y. Zhang et al. CLINICAL CANCER RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search